Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris

Heart

Volumn 87, Issue 5, 2002, Pages 415-422

  Forslund, L ^a   Bjorkander I ^a   Ericson, M ^b   Held, C ^a   Kahan, T ^a   Rehnqvist, N ^c   Hjemdahl, Paul ^d  

^a DANDERYD HOSPITAL   (Sweden)

^b MID SWEDEN UNIVERSITY   (Sweden)

^c NATIONAL BOARD OF HEALTH AND WELFARE   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; METOPROLOL; METOPROLOL TARTRATE; VERAPAMIL;

ADRENALIN URINE LEVEL; ADULT; AGED; ANGINA PECTORIS; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINERGIC SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NERVE CONDUCTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0036238712     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.87.5.415     Document Type: Article

References (43)

1. The sympathetic nervous system and ischemic heart disease
2. The adrenergic system and prevention of myocardial damage by β-blockade: A clinical overview
3. Hemodynamic regulation: Investigation by spectral analysis
4. Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects
5. Heart rate variability in coronary artery disease
6. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction
7. Effects of atenolol and diltiazem on heart rate variability in normal persons
8. Effects of beta-blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction
9. Effects of beta-blockade on heart rate variability in patients with coronary artery disease
10. Plasma catecholamines: Analytical challenges and physiological limitations
11. How to assess sympathetic activity in humans
12. Resting venous plasma adrenaline in 70-year-old men correlated positively to survival in a population study: The significance of the physical working capacity
13. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
14. Comparison of neuroendocrine activation in patients with and without congestive heart failure: A substudy of the studies on left ventricular dysfunction (SOLVD)
15. Two-year time course and significance of neurohormonal activation in the survival and ventricular enlargement (SAVE) study
16. Heart rate variability: A contribution to a better understanding of the clinical role of heart rate
17. Heart rate variability: Standards of measurements, physiological interpretation and clinical use
18. Cardiovascular neural regulation explored in the frequency domain
19. Frequency domain measurements of heart period variability to assess risk late after myocardial infarction
20. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction
21. Usefulness of the addition of heart rate variability to Holter monitoring in predicting in-hospital cardiac events in patients with unstable angina pectoris
22. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham heart study
23. Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function
24. Heart rate variability and ischemia in patients with coronary heart disease and stable angina pectoris: Influence of drug therapy and prognostic value
25. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The angina prognosis study in Stockholm (APSIS)
26. Ischemia during exercise and ambulatory monitoring in patients with stable angina pectoris and healthy controls: Gender differences and relationships to catecholamines
27. Catecholamine measurements in plasma by high-performance liquid chromatography with electrochemical detection
28. Catecholamine measurements in urine by high-performance liquid chromatography with amperometric detection: Comparison with an autoanalyser fluorescence method
29. Spectrum analysis: A modern perspective
30. Heart rate variability in healthy subjects is related to age and gender
31. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil
32. Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the angina prognosis study in Stockholm [APSIS])
33. Frequency domain heart rate variability and plasma norepinephrine levels in the coronary sinus during handgrip exercise
34. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure
35. Comparison of different methods for assessing sympathovagal balance in chronic congestive heart failure secondary to coronary artery disease
36. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients
37. Effects of bisoprolol on heart rate variability in heart failure
38. Influence of beta-adrenoceptor blockade by metoprolol and propranolol on plasma concentrations and effects of noradrenaline and adrenaline during i.v. infusion
39. Plasma noradrenaline as an index of sympathetic tone in coronary arterial disease: The confounding influence of clearance of noradrenaline
40. Effects of verapamil on indexes of heart rate variability after acute myocardial infarction
41. Effects of calcium antagonists on plasma norepinephrine levels, heart rate and blood pressure
42. Calcium antagonist treatment, sympathetic activity and platelet function
43. Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris